171 related articles for article (PubMed ID: 37301185)
21. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
Nagata H; Hatano E; Tada M; Murata M; Kitamura K; Asechi H; Narita M; Yanagida A; Tamaki N; Yagi S; Ikai I; Matsuzaki K; Uemoto S
Hepatology; 2009 Jun; 49(6):1944-53. PubMed ID: 19418558
[TBL] [Abstract][Full Text] [Related]
23. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis.
Yamaguchi T; Yoshida K; Murata M; Suwa K; Tsuneyama K; Matsuzaki K; Naganuma M
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682957
[TBL] [Abstract][Full Text] [Related]
24. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
Yoshida K; Murata M; Yamaguchi T; Matsuzaki K; Okazaki K
J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26771649
[TBL] [Abstract][Full Text] [Related]
25. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study.
Lv SL; Guo P; Zou JR; Chen RS; Luo LY; Huang DQ
World J Gastrointest Oncol; 2024 Jan; 16(1):118-132. PubMed ID: 38292835
[TBL] [Abstract][Full Text] [Related]
27. Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.
Deng YR; Yoshida K; Jin QL; Murata M; Yamaguchi T; Tsuneyama K; Moritoki Y; Niu JQ; Matsuzaki K; Lian ZX
Clin Exp Immunol; 2014 Apr; 176(1):102-11. PubMed ID: 24372395
[TBL] [Abstract][Full Text] [Related]
28. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
[TBL] [Abstract][Full Text] [Related]
29. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.
Nakamura N; Yoshida K; Tsuda R; Murata M; Yamaguchi T; Suwa K; Ichimura M; Tsuneyama K; Matsuzaki K; Nakano T; Hirohara J; Seki T; Okazaki K; Gershwin ME; Naganuma M
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1480-1492. PubMed ID: 34994163
[TBL] [Abstract][Full Text] [Related]
30. Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas.
Hori Y; Ikeura T; Yamaguchi T; Yoshida K; Matsuzaki K; Ishida M; Satoi S; Okazaki K
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):581-589. PubMed ID: 32532597
[TBL] [Abstract][Full Text] [Related]
31. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
[TBL] [Abstract][Full Text] [Related]
32. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation.
Mahmoud AM; Mohammed HM; Khadrawy SM; Galaly SR
Chem Biol Interact; 2017 Nov; 277():146-158. PubMed ID: 28935427
[TBL] [Abstract][Full Text] [Related]
33. Astragaloside IV Induces Apoptosis, G
Su CM; Wang HC; Hsu FT; Lu CH; Lai CK; Chung JG; Kuo YC
In Vivo; 2020; 34(2):631-638. PubMed ID: 32111763
[TBL] [Abstract][Full Text] [Related]
34. Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α.
Zheng J; Kim SJ; Saeidi S; Kim SH; Fang X; Lee YH; Guillen-Quispe YN; Ngo HKC; Kim DH; Kim D; Surh YJ
Free Radic Biol Med; 2023 Jan; 194():347-356. PubMed ID: 36460215
[TBL] [Abstract][Full Text] [Related]
35. Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.
Yang R; Song C; Chen J; Zhou L; Jiang X; Cao X; Sun Y; Zhang Q
Phytomedicine; 2020 Apr; 69():153211. PubMed ID: 32259676
[TBL] [Abstract][Full Text] [Related]
36. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis
Zhang Q; Liu J; Duan H; Li R; Peng W; Wu C
J Adv Res; 2021 Dec; 34():43-63. PubMed ID: 35024180
[TBL] [Abstract][Full Text] [Related]
37. Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor-E2-related factor 2/haem oxygenase (HO)-1 signalling pathway.
Liu L; Shang Y; Li M; Han X; Wang J; Wang J
Clin Exp Pharmacol Physiol; 2015 May; 42(5):520-9. PubMed ID: 25739561
[TBL] [Abstract][Full Text] [Related]
38. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
39. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
40. Phospho-Smad3L promotes progression of hepatocellular carcinoma through decreasing miR-140-5p level and stimulating epithelial-mesenchymal transition.
Hu X; Han D; Wang Y; Gu J; Wang X; Jiang Y; Yang Y; Liu J
Dig Liver Dis; 2021 Oct; 53(10):1343-1351. PubMed ID: 33775574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
